Literature DB >> 25171454

Refractory sacrococcygeal germ cell tumor in Schinzel-Giedion syndrome.

Kenji Kishimoto1, Ryoji Kobayashi, Nozomi Yonemaru, Hiroshi Yamamoto, Takao Tsujioka, Hirozumi Sano, Daisuke Suzuki, Kazue Yasuda, Masahiko Suzuki, Akiko Ando, Hidefumi Tonoki, Susumu Iizuka, Kimiaki Uetake, Kunihiko Kobayashi.   

Abstract

We describe a boy with Schinzel-Giedion syndrome who developed refractory sacrococcygeal germ cell tumor with elements of embryonal carcinoma and immature teratoma. He developed local recurrence soon after tumor resection. The tumor was highly resistant to platinum-based combination chemotherapy, local irradiation, and salvage chemotherapy. Frequent infections resulted in a delay in treatment, although apparent fragility had not been observed clinically. He died from tumor progression at 32 months of age. Intensification of chemotherapy does not seem to be feasible for tumors in patients with Schinzel-Giedion syndrome.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25171454     DOI: 10.1097/MPH.0000000000000236

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  4 in total

1.  [Unusual facies with delayed development and multiple malformations in a 14-month-old boy].

Authors:  Tong Lu; Yi Wang
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2017-08

Review 2.  Schinzel-Giedion syndrome: a novel case, review and revised diagnostic criteria.

Authors:  Wei-Liang Liu; Zhi-Xu He; Fang Li; Rong Ai; Hong-Wei Ma
Journal:  J Genet       Date:  2018-03       Impact factor: 1.166

Review 3.  A practical guide for evaluating gonadal germ cell tumor predisposition in differences of sex development.

Authors:  Louise C Pyle; Katherine L Nathanson
Journal:  Am J Med Genet C Semin Med Genet       Date:  2017-05-25       Impact factor: 3.908

Review 4.  SETBP1 dysregulation in congenital disorders and myeloid neoplasms.

Authors:  Nicoletta Coccaro; Giuseppina Tota; Antonella Zagaria; Luisa Anelli; Giorgina Specchia; Francesco Albano
Journal:  Oncotarget       Date:  2017-04-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.